Goldman Sachs

Goldman Sachs’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Goldman Sachs’s Portfolio NBRV Stock Details NBRV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell
2020 Q3	$30K	Buy
2020 Q2	$9K	Sell
2020 Q1	$69K	Buy
2019 Q2	–	Sell
2019 Q1	$327K	Buy
2018 Q4	$33K	Sell
2018 Q3	$190K	Sell
2018 Q2	$312K	Buy
2018 Q1	$381K	Sell
2017 Q4	$637K	Buy